Stockscreener 앱 받기
0.00
100.00%
-79.97
전일 마감가:
$79.97
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$4.68B
수익:
$574.50M
순이익/손실:
$-78.58M
주가수익비율:
0.00
EPS:
-1.35
순현금흐름:
$1.58M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$79.99
Inari Medical Inc Stock (NARI) Company Profile
명칭
Inari Medical Inc
전화
949-923-4747
주소
6001 OAK CANYON, SUITE 100, IRVINE, CA
NARI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NARI
Inari Medical Inc
|
0.00 | 4.68B | 574.50M | -78.58M | 1.58M | -1.35 |
|
ABT
Abbott Laboratories
|
128.85 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
101.90 | 138.41B | 17.55B | 2.03B | 2.37B | 1.37 |
|
SYK
Stryker Corp
|
365.06 | 129.62B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
84.16 | 107.92B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.04 | 40.53B | 5.54B | 4.18B | 259.90M | 7.00 |
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 개시 | Oppenheimer | Outperform |
| 2024-09-18 | 개시 | Stifel | Hold |
| 2024-09-03 | 개시 | Leerink Partners | Market Perform |
| 2024-08-09 | 개시 | Deutsche Bank | Buy |
| 2024-07-25 | 개시 | William Blair | Outperform |
| 2024-07-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-02-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-23 | 개시 | Needham | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-09-29 | 개시 | Berenberg | Buy |
| 2022-09-13 | 개시 | Truist | Hold |
| 2022-06-21 | 개시 | Piper Sandler | Overweight |
| 2022-03-23 | 재개 | BofA Securities | Buy |
| 2020-12-15 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-11-18 | 개시 | BTIG Research | Buy |
| 2020-10-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-09-28 | 개시 | SVB Leerink | Outperform |
| 2020-06-19 | 개시 | Canaccord Genuity | Buy |
| 2020-06-16 | 개시 | BofA/Merrill | Neutral |
| 2020-06-16 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-16 | 개시 | Wells Fargo | Equal Weight |
모두보기
Inari Medical Inc 주식(NARI)의 최신 뉴스
Press Release Distribution & PR Platform - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc.(NARI) Shareholders - ACCESS Newswire
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Inari Medical stock soars to 52-week high of $79.95 - MSN
Paul Mullen Chosen to Lead Microbot Medical’s U.S. Sales Force - Medical Product Outsourcing
Imperative Care Expands Precision Thrombectomy Portfolio - Diagnostic and Interventional Cardiology
Inari Medical, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Inari Medical, Inc. (NARI) - ACCESS Newswire
NARI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLCRECOGNIZED INVESTOR COUNSELReminds Inari Medical, Inc. Shareholders to Lead Class Action Lawsuit! - ACCESS Newswire
Inari Medical introduces thrombectomy system for arterial thrombus cases - Yahoo Finance
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases - PR Newswire
NARI STOCK ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
Microbot Medical Appoints Seasoned Endovascular Sales - GlobeNewswire
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System - The Manila Times
Can This Executive From a $4.94B Acquired Company Drive Microbot's Robotic System to Market Success? - StockTitan
Inari Medical, Inc. Class Action: Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024NARI - accessnewswire.com
INARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, I - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Shareholders - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire
Shareholders that lost money on Inari Medical, Inc.(NARI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Is Inari Medical, Inc. (NARI) the Hottest Smid-Cap Stock So Far In 2025? - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Shareholder Rights Advocates at Levi & Korsinsky Investigate Inari Medical, Inc. (NARI) Regarding Possible Securities Fraud Violations - accessnewswire.com
NARI ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Inari Medical, Inc. investment - ACCESS Newswire
Inari Medical Inc to Host Earnings Call - ACCESS Newswire
An Investigation Has Commenced on Behalf of Inari Medical, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your NARI Losses. - ACCESS Newswire
Inari Medical, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before July 12, 2024 to Discuss Your RightsNARI - ACCESS Newswire
Inari Medical, Inc. (NARI) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Inari Medical, Figs Inc, Fastly, and Ryvyl Investigation - GlobeNewswire
Inari Medical, Figs Inc, Fastly, and Ryvyl Investigation Alert: Johnson Fistel, LLP Encourages Long-Term - EIN News
Stryker grows cardiovascular division with Inari Medical acquisition - Yahoo Finance
Levi & Korsinsky Reminds Inari Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024NARI - ACCESS Newswire
Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNARI - ACCESS Newswire
Stryker Completes Acquisition of Inari Medical Inc. for $4.94 BillionOn February 19, 2025, Stryker Corporation finalized the acquisition of Inari Medical, Inc., marking a significant strategic move for the company. The acquisition was completed in al - Defense World
Inari Medical, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsNARI - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Stryker Completes $4.9 Billion Acquisition of Inari - Orange County Business Journal
Stryker completes $4.94 billion Inari Medical acquisition By Investing.com - Investing.com South Africa
Stryker concludes Inari Medical acquisition for $4.9bn - Yahoo Finance
Stryker Corporation (SYK) Completes Acquisition of Inari Medical - GuruFocus.com
Inari Medical, Inc. (NARI): the Best Performing Healthcare Stock So Far in 2025 - Insider Monkey
10 Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey
Stryker Completes Acquisition Of Inari Medical -February 19, 2025 at 10:19 am EST - Marketscreener.com
Inari Medical Inc (NARI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.01%
0.60%
자본화:
|
볼륨(24시간):